Annovis Bio (ANVS) Non Operating Income (2019 - 2026)
Annovis Bio (ANVS) posted Non Operating Income of -$443,103 for Q2 2026, compared with $51,395 a year earlier.
Powered by 
Analysis
Annovis Bio (ANVS) Non Operating Income (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at Annovis Bio was $6,751; for FY2025, it was $841,061, down 60.0% from FY2024.
- Annual Non Operating Income shows a five-year compound annual growth rate of -6.5% (FY2020 to FY2025).
- In prior years, Annovis Bio's Non Operating Income was $2.1 million in FY2024, -$11.17 million in FY2023, $182,712 in FY2022 (+264.8%) and $50,089 in FY2021 (-95.7%).
- The Q2 2026 figure stands as the lowest quarterly Non Operating Income since Q3 2024.
- The strongest year-over-year quarter for Non Operating Income in the past five years was Q3 2022, with growth of 852.2%; the weakest was Q3 2021, with a decline of 99.1%.
- According to Business Quant data, Non Operating Income for the three prior quarters was $405,800 (Q1 2026), -$128,263 (Q4 2025) and $172,317 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | - |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Annovis Bio | 32.15 Mn | -35.63 Mn | - | -443,103.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -443,103.00 |
| Mar 31, 2026 | 405,800.00 |
| Dec 31, 2025 | -128,263.00 |
| Sep 30, 2025 | 172,317.00 |
| Jun 30, 2025 | 51,395.00 |
| Mar 31, 2025 | 745,612.00 |
| Dec 31, 2024 | 870,213.00 |
| Sep 30, 2024 | -8.25 Mn |
| Jun 30, 2024 | 2.74 Mn |
| Mar 31, 2024 | 6.74 Mn |
| Dec 31, 2023 | -11.77 Mn |
| Sep 30, 2023 | 146,655.00 |
| Jun 30, 2023 | 222,578.00 |
| Mar 31, 2023 | 232,535.00 |
| Dec 31, 2022 | 74,153.00 |
| Sep 30, 2022 | 52,886.00 |
| Jun 30, 2022 | 36,024.00 |
| Mar 31, 2022 | 19,649.00 |
| Dec 31, 2021 | 5,450.00 |
| Sep 30, 2021 | 5,554.00 |
API Access
Annovis Bio Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ANVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ANVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ANVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();